PT - JOURNAL ARTICLE AU - Mengkai Shieh AU - Tristan J. Hayeck AU - Anh Dinh AU - Jamie L. Duke AU - Nilesh Chitnis AU - Timothy Mosbruger AU - Ryan P. Morlen AU - Deborah Ferriola AU - Carolina Kneib AU - Taishan Hu AU - Yanping Huang AU - Dimitri S. Monos TI - A Combined HLA Molecular Mismatch and Expression Analysis for Evaluating HLA-DPB1 <em>de novo</em> Donor-Specific Antibody Risk in Pediatric Solid Organ Transplantation: Implications for Solid Organ &amp; Hematopoietic Stem Cell Transplantation AID - 10.1101/2020.01.06.20016709 DP - 2020 Jan 01 TA - medRxiv PG - 2020.01.06.20016709 4099 - http://medrxiv.org/content/early/2020/01/10/2020.01.06.20016709.short 4100 - http://medrxiv.org/content/early/2020/01/10/2020.01.06.20016709.full AB - Background HLA molecular mismatch (MM) has been shown to be a risk factor for de novo donor-specific antibody (dnDSA) development in solid organ transplantation (SOT). HLA expression differences have also been associated with adverse outcomes in hematopoietic cell transplantation. We sought to study both MM and expression in assessing dnDSA risk.Methods One-hundred-and-three HLA-DP-mismatched SOT pairs were retrospectively analysed. MM was computed using amino acids (aa), eplets and, supplementarily, Grantham/Epstein scores. DPB1 alleles were classified as rs9277534-A (low-expression) or -G (high-expression)–linked. To determine the associations between risk factors and dnDSA, logistic regression, linkage disequilibrium (LD) and population-based analyses were performed.Results A high-risk AA:GX (recipient:donor) expression combination (X=A or G) demonstrated strong association with DP-dnDSA (p=0.001). MM was also associated with DP-dnDSA when evaluated by itself (eplet_p=0.007, aa_p=0.003, Grantham_p=0.005, Epstein_p=0.004). When attempting to determine the relative individual effects of the risk factors in multivariable analysis, only AA:GX expression status retained a strong association (RR=18.6, p=0.007 with eplet; RR=15.8, p=0.02 with aa), while MM was no longer significant (eplet_p=0.56, aa_p=0.51). Importantly, these risk factors are correlated, due to LD between the expression-tagging SNP and polymorphisms along HLA-DPB1.Conclusions The MM and expression risk factors each appear to be strong predictors of DP-dnDSA and to possess clinical utility; however, the two risk factors are closely correlated. These metrics may represent distinct ways of characterizing a common overlapping dnDSA risk profile, but they are not independent. Further, we demonstrate the importance and detailed implications of LD effects in risk assessment of dnDSA and possibly transplantation overall.Competing Interest StatementJ.L.D., D.F., and D.S.M. receive royalties from Omixon Inc.Funding StatementThis work was supported by institutional funds from The Children’s Hospital of Philadelphia to D.S.M. Neither the authors nor their institutions received payment or services at any time from a third party for any aspect of the submitted work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data contained in this study can be made available upon reasonable request.aaamino acidCHOPChildren’s Hospital of PhiladelphiadnDSAde novo donor-specific antibodyFWPfrequency-weighted permutationGVHDgraft versus host diseaseHLAhuman leukocyte antigenHSCThematopoietic stem cell transplantationIRBInstitutional Review BoardLDlinkage disequilibriumMFImean fluorescence intensityMMmolecular mismatchMW-UMann-Whitney U testNGSnext-generation sequencingSABsingle-antigen beadSDCsupplemental digital contentSNPsingle-nucleotide polymorphismSOTsolid-organ transplantationTCET-cell epitope